期刊文献+

咪达唑仑和右美托咪定对危重脓毒症患者的炎性反应和胃黏膜pH值的影响 被引量:3

Effects of dexmedetomidine and midazolam on inflammatory response and gastric intramucosal pH in critically ill patients with sepsis
下载PDF
导出
摘要 目的 对比咪达唑仑和右美托咪啶对炎性反应相关指标和胃黏膜pH值的影响.方法 将40例脓毒症患者随机分为咪达唑仑组(n =20,M组)和右美托咪定组(n=20,D组),用ELASE法检测TNF-α,IL-1β和IL-6水平,使用标准的pH值和血气分析仪同时分析和计算胃黏膜pH值.结果 D组与M组间血流动力学、生化指标和胃黏膜pH值差异无统计学意义,而24 h后D组较M组心率[(86±3.37)和(110 ±3.29) bpm],TNF-α[(19.3±5.6)和(14.5 ±4.1)pg/mL],IL-1β[(6.29±2)和(5±0.32) pg/mL],IL-6[(457.4±337.2)和(215.6±194.3) pg/mL]均有显著性降低(P<0.05).结论 右美托咪定用于脓毒症患者的镇静可有效减轻炎性反应. ObjeetiYe To study the effect of midazolam and dexmedetomidine on the inflammato- ry-response related indicators and gastric intramucosal pH in critically ill patients with sepsis. Methods Fonrty patients with sepsis were allocated into the dexmedetomidine group ( n = 20, Group D) and midazo- lam group (n = 20, Group M). Arterial blood was taken and analysed with standard pH and blood-gas anal- ysers. Tumor necrosis factor-α ( TNF-α ), interleukin-1β ( IL-1β ), and interleukin-6 ( IL-6 ) levels were measured with ELASE method. Results There were no statistically significant differences in haemody- namic and biochemical measurements and gastric intramucosal pH between the groups. Compared with Group M,the levels of Group D in heart rate( 110 ± 3.29 vs 86 ± 3.37 bpm) ,TNF-α( 19.3 ± 5.6 vs 14.5 _±4.1 pg/mL) ,IL-113(6.29 ±2 vs5_±0.32 pg/mL) and IL-6(457.4 ±337.2 vs 215.6 _±194.3 pg/ mL) were significant decreased after 24 hours ( P 〈 0.05 ). Conclusion Dexmedetomidine may alleviate inflammatory effects in sepsis patients during sedation.
出处 《临床外科杂志》 2013年第12期965-967,共3页 Journal of Clinical Surgery
关键词 咪达唑仑 右美托咪啶 脓毒症 炎性反应 胃黏膜PH值 midazolam dexmedetomidine sepsis SRIS gastric intramucosal pH
  • 相关文献

参考文献15

  • 1Dellinger RP,Levy MM,Rhodes A. Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock,2012[J].{H}Intensive Care Medicine,2013,(02):165-228.
  • 2Romero-Bermejo FJ,Ruiz-Bailen M,Gil-Cebrian J. Sepsis-induced cardiomyopathy[J].Curr Cardiol Rev,2011,(03):163-183.
  • 3Jozwiak M,Persichini R,Monnet X. Management of myocardial dysfunction in severe sepsis[J].{H}Seminars in respiratory and critical care medicine,2011,(02):206-214.
  • 4Court O,Kumar A,Parrillo JE. Clinical review:Myocardial depression in sepsis and septic shock[J].{H}CRITICAL CARE,2002,(06):500-508.
  • 5Qiu P,Cui X,Barochia A. The evolving experience with therapeutic TNF inhibition in sepsis:considering the potential influence of risk of death[J].{H}Expert Opinion on Investigational Drugs,2011,(11):1555-1564.
  • 6Kang S,Yang Y,Li CJ. Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction:a meta-analysis of randomized controlled trials[J].{H}Clinical Therapeutice,2007,(11):2406-2418.
  • 7Tao F,Peng L,Li J. Association of serum myeloid cells of soluble triggering reeeptor-1 level with myocardial dysfunction in patients with severe sepsis[J].{H}Mediators of Inflammation,2013.819246.
  • 8Cain BS,Meldrum DR,Dinarello CA. Tumor necrosis factor-αand interleukin-1β synergistically depress human myocardial function[J].{H}CRITICAL CARE MEDICINE,1999,(07):1309-1318.
  • 9Yoon SH. Concerns of the anesthesiologist:anesthetic induction in severe sepsis or septic shock patients[J].Korean J Anesthesiol,2012,(01):3-10.
  • 10Yuki K,Soriano SG,Shimaoka M. Sedative drug modulates T-cell and lymphocyte function-associated antigen-1 function[J].{H}Anesthesia and Analgesia,2011,(04):830-838.

同被引文献25

  • 1纪木火,吴晶,李仁奇,田蜜,朱四海,李伟彦,杨建军.右旋美托咪啶对脓毒血症大鼠急性肺损伤的影响[J].中华临床医师杂志(电子版),2011,5(21):6434-6436. 被引量:10
  • 2Vincent JL, Opal SM, Marshall JC, et al. Sepsis defini-tions :time for change[J]. Lancet, 2013, 381(9868): 774-775.
  • 3Dellinger RP,Levy MM, Rhodes A, et al. Surviving SepsisCampaign : international guidelines for management of se-vere sepsis and septic shock, 2012[J]. Intens Care Med,2013,39(2): 165-228.
  • 4Rauch PJ, Chudnovskiy A, Robbins CS, et al. Innate re-sponse activator B cells protect against microbial sepsis [J].Science, 2012,335(6068): 597-601.
  • 5Hotchkiss RS, Monneret G, Payen D. Immunosuppressionin sepsis: a novel understanding of the disorder and a newtherapeutic approach [J]. Lancet Infec Dis, 2013, 13(3):260-268.
  • 6Taniguchi T, Kidani Y, Kanakura H, et al. Effects ofdexmedetomidine on mortality rate and inflammatory respons-es to endotoxin-induced shock in rats[J]. Crit Care Med,2004,32(6):1322-1326.
  • 7Oka z a k i Y , M a t s u k a w a A. Pathophysiology of sepsis a n d recent patentso n the diagnosis, treatment a n d prophylaxis for sepsis [J]. R e c e n t PatI n f l a m m Allergy D r u g Discov, 2 0 0 9 , 3 ( 1 ) :2 6 - 32.
  • 8Calfee C S , Matthay M A . Clinical i m m u n o l o g y : culprits with evolutinaryties [J]. Nature, 2 0 1 0 , 4 6 4 ( 7 2 8 5 ) :4 1 - 4 2 .
  • 9A u g u s D C , Linde - Zwirble W T , Lidicker J, et al. Epidemiology of severesepsis in the United States : analysis of incidence, o u t c o m e , a n d associatedcosts of care[J]. Crit Crare M e d , 2 0 0 1 , 2 9 ( 7 ) :1 3 0 3 - 1 3 1 0 .
  • 10J akob S M , E s k o R R , Michael G , et al. D e x m e d e t o m i d i n e vs m i d a z o l a mor propofol for sedation during prolonged mechanical ventilation : two rando m i z e d controlled trials[J]. J A M A , 2 0 1 2 , 3 0 7 ( 1 1 ) :1 1 5 1 - 1 1 6 0 .

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部